{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Sarah Cockayne, Alison Pighills, Joy Adamson, Caroline Fairhurst, Shelley Crossland, Avril Drummond, Catherine E Hewitt, Sara Rodgers, Sarah J Ronaldson, Jennifer McCaffery, Katie Whiteside, Arabella Scantlebury, Lyn Robinson-Smith, Ann Cochrane, Sarah E Lamb, Sophie Boyes, Simon Gilbody, Clare Relton & David J Torgerson.

Sarah Cockayne ^1,*, Alison Pighills ^2,3, Joy Adamson ¹, Caroline Fairhurst ¹, Shelley Crossland ⁴, Avril Drummond ⁵, Catherine E Hewitt ¹, Sara Rodgers ¹, Sarah J Ronaldson ¹, Jennifer McCaffery ¹, Katie Whiteside ¹, Arabella Scantlebury ¹, Lyn Robinson-Smith ¹, Ann Cochrane ¹, Sarah E Lamb ⁶, Sophie Boyes ⁷, Simon Gilbody ¹, Clare Relton ⁸, David J Torgerson ¹

¹ York Trials Unit, Department of Health Sciences, University of York, York, UK
² Mackay Institute of Research and Innovation, Queensland Health, Mackay Base Hospital, Mackay, QLD, Australia
³ Division of Tropical Health and Medicine, James Cook University, Townsville, QLD, Australia
⁴ Leicestershire Partnership NHS Trust, Leicester, UK
⁵ School of Health Sciences, University of Nottingham, Nottingham, UK
⁶ Institute of Health Research, College of Medicine and Health, University of Exeter, Exeter, UK
⁷ York Teaching Hospital NHS Foundation Trust, York, UK
⁸ Institute of Population Health Sciences, Queen Mary University of London, London, UK
^* Corresponding author Email: sarah.cockayne@york.ac.uk

Declared competing interests of authors: Catherine E Hewitt declares membership of the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Commissioning Sub-board (EOI) (2016–17). Sarah E Lamb was a member of Clinical Trial Units funded by NIHR and declares previous membership of the HTA Additional Capacity Funding Board (2012–15), the HTA End of Life Care and Add-on Studies Board (2015), the HTA Prioritisation Group Board and the HTA Trauma Board. Simon Gilbody declares that he was deputy chairperson of the NIHR HTA programme Commissioning Committee from 1 November 2016 to 30 October 2019. Joy Adamson is a member of HTA Commissioning Board (August 2017–present). David J Torgerson declares that he was a member of Clinical Trial Units funded by NIHR, a member of various HTA commissioning boards and a member of the NIHR Clinical Trial Units Standing Advisory Committee (2010–14). Avril Drummond declares that she is a member (June 2017–present) of the NIHR Academy, Clinical Lectureship and Senior Lectureship Panel and is now deputy chairperson (January 2020–present).